Prolonged Progression-Free Survival with Partial Disease Regression in Advanced Metastatic Medullary Thyroid Carcinoma Treated with Vandetanib

MLA

David S. Rosenthal, et al. “Prolonged Progression-Free Survival with Partial Disease Regression in Advanced Metastatic Medullary Thyroid Carcinoma Treated with Vandetanib.” AACE Clinical Case Reports, vol. 4, Sept. 2018, pp. e432–36. EBSCOhost, https://doi.org/10.4158/accr-2018-0079.

APA

David S. Rosenthal, Sravanthi Sanivarapu, Zahily Sardiñas, Wondwossen Gebre, Minakshi Ramchand, & Salini Chellappan Kumar. (2018). Prolonged Progression-Free Survival with Partial Disease Regression in Advanced Metastatic Medullary Thyroid Carcinoma Treated with Vandetanib. AACE Clinical Case Reports, 4, e432–e436. https://doi.org/10.4158/accr-2018-0079

Chicago

David S. Rosenthal, Sravanthi Sanivarapu, Zahily Sardiñas, Wondwossen Gebre, Minakshi Ramchand, and Salini Chellappan Kumar. 2018. “Prolonged Progression-Free Survival with Partial Disease Regression in Advanced Metastatic Medullary Thyroid Carcinoma Treated with Vandetanib.” AACE Clinical Case Reports 4 (September): e432–36. doi:10.4158/accr-2018-0079.